|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00690 UNI-BIO GROUP
Nominal 
0.063 0.000 (0.000%) Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| ROAA (%) | 20.179% | 13.753% | -7.531% | -25.973% | 0.913% |
| ROAE (%) | 31.367% | 20.871% | -10.773% | -33.105% | 1.110% |
| Return on Capital Employed (%) | 24.009% | 19.045% | -11.176% | -37.079% | 1.017% |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Gross Profit Margin (%) | 81.041% | 76.055% | 78.382% | 86.741% | 86.664% |
| EBITDA Margin (%) | 19.024% | 13.607% | 0.239% | -24.163% | 12.682% |
| Pre-tax Profit Margin (%) | 15.659% | 9.831% | -5.663% | -33.979% | 2.454% |
| Net Profit Margin (%) | 14.622% | 8.746% | -5.543% | -34.161% | 1.174% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Current Ratio (X) | 2.074 X | 2.220 X | 2.185 X | 3.005 X | 3.525 X |
| Quick Ratio (X) | 1.757 X | 1.845 X | 1.755 X | 2.732 X | 3.281 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Total Liabilities / Total Assets(%) | 37.273% | 33.414% | 34.861% | 25.050% | 18.554% |
| Total Debt / Total Assets (%) | 13.732% | 7.752% | 2.092% | 1.242% | 0.513% |
| Net Debt / Total Assets (%) | -17.790% | -25.830% | -29.153% | -8.656% | -21.817% |
| Total Debt / Shareholders' Funds (%) | 21.891% | 11.642% | 3.212% | 1.657% | 0.630% |
| Long Term Debt / Shareholders' Funds (%) | 14.621% | 3.836% | 0.565% | 1.112% | 0.167% |
| Net Debt / Shareholders' Funds (%) | -28.361% | -38.791% | -44.755% | -11.548% | -26.787% |
| Net Cash / (Debt) ($) | 72.937M | 75.544M | 78.011M | 21.874M | 64.677M |
| Net Cash / (Debt) per share ($) | 0.011 | 0.012 | 0.012 | 0.003 | 0.010 |
| Total Debt / Capital Employed (%) | 19.071% | 11.212% | 3.194% | 1.631% | 0.629% |
| Interest Coverage Ratio (X) | 97.935 X | 116.125 X | N/A | N/A | 7.862 X |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Inventory Turnover (Day) | 139.494 Day | 127.333 Day | 134.318 Day | 196.833 Day | 208.132 Day |
| Receivables Turnover (Day) | 41.825 Day | 53.674 Day | 75.600 Day | 127.491 Day | 96.696 Day |
| Payables Turnover (Day) | 5.489 Day | 4.364 Day | 4.697 Day | 4.925 Day | 1.645 Day |
| Remarks: | Real time quote last updated: 25/11/2024 07:52 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 67,382,000 |
| %Change | 71.016% |
| EPS / (LPS) | HKD 0.011 |
| NBV Per Share ($) | HKD 0.051 |